Staged scleroobliteration in the complex treatment of varicose veins of the lower extremities in the elderly

Annotation. Varicose veins of the lower extremities tend to be more common in older age groups, whose treatment is complicated by comorbidity and advanced pathology. The aim is to develop an effective, safe and economical method of treating varicose veins of the lower extremities in elderly and senile patients. We monitored 69 patients who underwent scleroobliteration and compression therapy. The first group – 31 patients aged 67-83 years with pronounced comorbidity, limited mobility and difficulties with the use of compression knitwear. The aescinic salt of 2,6-diaminohexanoic acid was used in the form of a 0.1% solution. After the session, an elastic bandage, a compression product of 15–20 mm Hg, or a combination thereof was applied to the lower leg. The patients followed the movement regime available to them. The second group – 38 patients aged 23-51 years. Lauromacrogol 400 (polidocanol) was used in the form of a foam form of a 3% solution. After the session, a compression product of 23-32 mm Hg was used. Statistical methods of processing: Student’s test and Fisher's angle transformer. It was found that course of the scleroobliteration session (character, duration and intensity of pain), early (sensation along the course of sclerosed veins, their nature, intensity and duration) and long-term (disappearance or degree of reduction of varicose veins, tissue condition in the area of sclerosed veins, frequency of recanalization) periods after scleroobliteration in patients of both groups was identical. In 16 patients of the 1st group, compression was performed for less time and not in full. Among them, thrombophlebitis occurred in one patient. Among the patients of the II group, compression defects were observed in 3 cases. Two of them developed thrombophlebitis (p<0.01). So staged scleroobliteration in the complex treatment of varicose veins of the lower extremities is an effective, safe, low-traumatic, simple, economical outpatient technology. Aescinic salt of 2,6-diaminohexanoic acid should be considered the drug of choice for scleroobliteration in elderly patients with limited mobility.